Loading clinical trials...
Loading clinical trials...
This is a randomized, double-blind, placebo-controlled, 24-week study to evaluate the efficacy and safety of AXS-02 in subjects with knee osteoarthritis associated with bone marrow lesions.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Axsome Therapeutics, Inc.
NCT05986292 · Osteoarthritis, Knee, Diabetic Neuropathic Pain, and more
NCT06234631 · Knee Replacement Surgery, Osteoarthritis, Knee
NCT07364578 · Osteoarthritis, Knee
NCT06488144 · Osteoarthritis, Knee
NCT07058623 · Arthroplasty, Replacement, Knee, Osteoarthritis, Knee
Achieve Clinical Research
Birmingham, Alabama
Birmingham, Alabama
Chandler, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions